A phase Ill trial to evaluate the efficacy of uproleselan (GMI-1271) with chemotherapy in patients with relapsed/refractory acute myeloid leukemia.

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • DeAngelo, DJ; Erba, HP; Jonas, BA; O'Dwyer, M; Marlton, P; Huls, GA; Liesveld, J; Cooper, BW; Bhatnagar, B; Armstrong, M; Fogler, W; Chen, M; Magnani, J; Thackray, HM; Advani, AS; Becker, PS

Published Date

  • May 20, 2019

Published In

Volume / Issue

  • 37 / 15

Published By

Pages

  • 2

Electronic International Standard Serial Number (EISSN)

  • 1527-7755

International Standard Serial Number (ISSN)

  • 0732-183X

Conference Name

  • Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)

Conference Location

  • Chicago, IL

Conference Start Date

  • May 31, 2019

Conference End Date

  • June 4, 2019